000 02963nam a22003137a 4500
999 _c12011
_d12011
001 PATH 2020 0003
003 PILC
005 20240720153216.0
008 211022b xxu||||| |||| 00| 0 eng d
040 _beng
_cFEU-NRMF MEDICAL LIBRARY
_erda
041 _aenglish
050 _aPATH 2020 0003
245 _aUndifferentiated uterine sarcoma :
_ba case report and review of diagnostic methods /
_cJan Paulo S. Pereira, Robert Glen R. Abesamis and Mari Karr A. Esguerra.
260 _aFairview, Quezon City:
_bDepartment of Pathology, FEU-NRMF,
_c2020.
300 _billustrations, tables, photos;
_c(in folder)
_ewith flash drive (soft copy).
336 _2rdacontent
_atext
337 _2rdamedia
_aunmediated
338 _2rdacarrier
_avolume
504 _aIncludes appendices and bibliographical references.
520 _a Abstract: Undifferentiated uterine sarcoma (UUS) is an extremely rare and notoriously aggressive form of endometrial stromal sarcomas (ESS) described to have high grade cytologic features without a specific type of differentiation. Outcome is very poor and its pathogenesis is currently unknown. Its low incidence limits its studies resulting to scarce amount of information both locally and internationally. It represents a diagnosis of exclusion making it both a clinical and a diagnostic dilemma. Therefore, arriving at an early diagnosis is extremely difficult. This case report aims to discuss UUS as a pathologic entity, review the utility of immunohistochemistry (IHC) when dealing with poorly differentiated uterine tumors, and briefly discuss molecular techniques used to diagnose this entity. We describe the case of a 69-year-old woman who presented with postmenopausal bleeding who subsequently underwent dilation and curettage. Her surgical pathology report revealed a poorly differentiated neoplasm with the following considerations but not limited to: high grade serous carcinoma, clear cell carcinoma, endometrial stromal sarcoma, and leiomyosarcoma. The patient, then, underwent extrafascial hysterectomy with bilateral salphingooophorectomy and bilateral lymph node dissection. Histomorphologic features revealed a poorly copy differentiated malignant tumor suggestive of underwent uterine sarcoma. An IHCpanel (ER, PR, cytokeratin, h-caldesmon, desmin, vimentin, CD10 and cyclin-D1) were them employed ultimately confirming the diagnosis of undifferentiated uterine sarcoma by eliminating other malignant conditions that mimic its histomorphologic gestures. By reporting this case, additional information will be added up to the already limited amount of studies found in the literature.
521 _aRESDPLD
650 _aendometrial stromal sarcomas
650 _aimmunohistochemistry
650 _apostmenopausal bleeding
700 _aPereira, Jan Paulo S., MD.
_eauthor
700 _aAbesamis, Robert Glen R., MD.
_eauthor
700 _aEsguerra, Mari Karr A., MD.
_eauthor
942 _2lcc
_cRU